Stock market unease causes listing of WSA subsidiary to be postponed

Due to recent falling prices on the stock exchange, WSA has postponed Friday's planned public entry of


Hearing company giant WS Audiology and private equity firm EQT have postponed taking online hearing aid trader public, according to multiple media outlets such as the Wall Street Journal on Thursday, and confirms this information.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

China approves Y-mabs drug

Y-mabs’ cancer treatment Danyelza, which is currently licensed to Sciclones, has been approved by the Chinese authorities. Y-mabs will receive double-digit sales royalties.

Further reading

Related articles

Latest news

See all jobs